BridgeMD
New treatment option for Obesity & Overweight
Official title Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome
ClinicalTrials.gov ID: NCT07703371
What this study is testing
- What it's testing
- Dietary fiber are components in foods that are not digested by human gastrointestinal enzymes (alpha amylase and alpha glucosidase) but are instead broken down and fermented by gut microbes. The byproducts generated during fermentation in the large intestine, primarily short-chain fatty acids (SCFA), bile acids, indoles, and their derivatives, circulate through the circulatory system to the liver, lungs, brain, adipose tissue, and muscles, where they modulate metabolism (suppress lipogenesis and alleviate insulin resistance) and immune function.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 60
You may be able to join if
- Adults aged 20-60 years.
- Willingness to provide informed consent.
- Willingness to consume Kodo millet porridge daily for 12 weeks.
- No planned changes in diet or physical activity during the study.
- Overweight or obese (BMI ≥ 25 kg/m²), placing them at risk for metabolic disorders.
You likely can't join if
- Known allergies to millet or any porridge ingredients.
- Individuals who are taking on-counter dietary fiber and probiotics supplements
- History of any chronic gastrointestinal diseases (e.g., IBD, gastritis, irritable bowel syndrome).
- Pregnant or lactating women.
- Antibiotic use in last 3 months.
- Alcohol abuse, more than 2 drink per day
See the full eligibility criteria
- Adults aged 20-60 years.
- Willingness to provide informed consent.
- Willingness to consume Kodo millet porridge daily for 12 weeks.
- No planned changes in diet or physical activity during the study.
- Overweight or obese (BMI ≥ 25 kg/m²), placing them at risk for metabolic disorders.
- Known allergies to millet or any porridge ingredients.
- Individuals who are taking on-counter dietary fiber and probiotics supplements
- History of any chronic gastrointestinal diseases (e.g., IBD, gastritis, irritable bowel syndrome).
- Pregnant or lactating women.
- Antibiotic use in last 3 months.
- Alcohol abuse, more than 2 drink per day
- Presence and usage of medications for any serious chronic illnesses, including uncontrolled diabetes (HbA1c \> 9), cardiovascular disease (aldosterone antagonists, alpha blockers, alpha-beta blockers, anticoagulants...
The study team makes the final eligibility decision.
Where it's taking place
- Mysore, Karnataka, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mysore, Karnataka, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.